U.S. stocks traded lower on Tuesday as investors rotated out of high-flying tech names, putting…
Read More »
Dell Technologies (DELL) has already delivered one of the market's most impressive rallies of 2026, but some analysts believe the…
Read More »
U.S. stocks traded higher on Friday as optimism around a potential U.S.-Iran truce and enthusiasm for AI infrastructure spending followed…
Read More »
Cybersecurity stocks are quietly reasserting themselves as one of the market’s strongest growth stories, even as attention remains firmly on…
Read More »
Zymeworks soared 34% after its partnered drug Ziihera posted strong Phase 3 data, with Jazz Pharmaceuticals showing it improved outcomes…
Read More »
Pacira jumped into M&A chatter after investor DOMA Perpetual urged a full sale, arguing the biotech could fetch $66/share. Activist…
Read More »
Nektar Therapeutics rises after reports of Eli Lilly’s buyout interest and strong Phase IIb results for REZPEG. With FDA Fast…
Read More »
Hims & Hers (HIMS) took a steep dive after U.S. regulators signaled an aggressive move against compounded versions of blockbuster…
Read More »
Shares of UnitedHealth Group (UNH) took a dive on Tuesday, leading a broad selloff across the health insurance sector after…
Read More »
Nanox’s planned acquisition of VasoHealthcare IT signals a strategic push to speed U.S. adoption of its AI imaging tech by…
Read More »
Cannabis stocks rallied this Friday after reports that the Trump administration is considering easing federal…
Read More »
